Homology Medicines approves 1-for-18 reverse stock split By Investing.com
Homology Medicines approves 1-for-18 reverse stock split
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.
Homology Medicines approves 1-for-18 reverse stock split
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of...